High US tariffs on China to propel India’s domestic API ecosystem & speed up generic drug global contracts
The Indian pharmaceutical industry will have to maximise its strength in API (active pharmaceutical ingredient) manufacturing and capitalize on favourable trade exemptions. The strategic approach will not only bolster India's position in the global …